Abbott Laboratories
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2007 | $5.18B | $3.53B | $1.66B | $429.7M |
| FY2008 | $6.99B | $5.71B | $1.29B | $347.0M |
| FY2009 | $7.28B | $6.19B | $1.09B | $366.4M |
| FY2010 | $8.74B | $7.72B | $1.02B | $387.2M |
| FY2011 | $8.97B | $7.48B | $1.49B | $383.0M |
| FY2012 | $9.31B | $7.52B | $1.80B | $433.0M |
| FY2013 | $3.32B | $2.18B | $1.15B | $262.0M |
| FY2014 | $3.68B | $2.60B | $1.08B | $246.0M |
| FY2015 | $2.97B | $1.86B | $1.11B | $292.0M |
| FY2016 | $3.20B | $2.08B | $1.12B | $310.0M |
| FY2017 | $5.57B | $4.44B | $1.14B | $406.0M |
| FY2018 | $6.30B | $4.91B | $1.39B | $477.0M |
| FY2019 | $6.14B | $4.50B | $1.64B | $519.0M |
| FY2020 | $7.90B | $5.72B | $2.18B | $546.0M |
| FY2021 | $10.53B | $8.65B | $1.89B | $640.0M |
| FY2022 | $9.58B | $7.80B | $1.78B | $685.0M |
| FY2023 | $7.26B | $5.06B | $2.20B | $644.0M |
| FY2024 | $8.56B | $6.35B | $2.21B | $673.0M |
| FY2025 | $9.57B | $7.40B | $2.17B | $664.0M |